294 related articles for article (PubMed ID: 28710314)
1. Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape.
Wang Z; Kim TB; Peng B; Karam J; Creighton C; Joon A; Kawakami F; Trevisan P; Jonasch E; Chow CW; Canales JR; Tamboli P; Tannir N; Wood C; Monzon F; Baggerly K; Varella-Garcia M; Czerniak B; Wistuba I; Mills G; Shaw K; Chen K; Sircar K
Clin Cancer Res; 2017 Nov; 23(21):6686-6696. PubMed ID: 28710314
[No Abstract] [Full Text] [Related]
2. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
Malouf GG; Ali SM; Wang K; Balasubramanian S; Ross JS; Miller VA; Stephens PJ; Khayat D; Pal SK; Su X; Sircar K; Tamboli P; Jonasch E; Tannir NM; Wood CG; Karam JA
Eur Urol; 2016 Aug; 70(2):348-57. PubMed ID: 26895810
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma.
Barnabas N; Amin MB; Pindolia K; Nanavati R; Amin MB; Worsham MJ
J Surg Oncol; 2002 May; 80(1):52-60. PubMed ID: 11967908
[TBL] [Abstract][Full Text] [Related]
5. Linking Binary Gene Relationships to Drivers of Renal Cell Carcinoma Reveals Convergent Function in Alternate Tumor Progression Paths.
Poehlman WL; Hsieh JJ; Feltus FA
Sci Rep; 2019 Feb; 9(1):2899. PubMed ID: 30814637
[TBL] [Abstract][Full Text] [Related]
6. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.
Bi M; Zhao S; Said JW; Merino MJ; Adeniran AJ; Xie Z; Nawaf CB; Choi J; Belldegrun AS; Pantuck AJ; Kluger HM; Bilgüvar K; Lifton RP; Shuch B
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2170-5. PubMed ID: 26864202
[TBL] [Abstract][Full Text] [Related]
7. Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinoma.
Köhn L; Svenson U; Ljungberg B; Roos G
Appl Immunohistochem Mol Morphol; 2015; 23(5):334-42. PubMed ID: 24992170
[TBL] [Abstract][Full Text] [Related]
8. Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
Kawakami F; Sircar K; Rodriguez-Canales J; Fellman BM; Urbauer DL; Tamboli P; Tannir NM; Jonasch E; Wistuba II; Wood CG; Karam JA
Cancer; 2017 Dec; 123(24):4823-4831. PubMed ID: 28832979
[TBL] [Abstract][Full Text] [Related]
9. Sarcomatoid Renal Cell Carcinoma: The Apple Doesn't Fall Far from the Tree.
Bergerot P; Agarwal N; Pal SK; Jones J
Clin Cancer Res; 2017 Nov; 23(21):6381-6383. PubMed ID: 28912138
[TBL] [Abstract][Full Text] [Related]
10. Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer.
Abbosh P; Sundararajan S; Millis SZ; Hauben A; Reddy S; Geynisman DM; Uzzo R
Eur Urol Focus; 2018 Dec; 4(6):969-971. PubMed ID: 28753842
[TBL] [Abstract][Full Text] [Related]
11. Genomics and clinical correlates of renal cell carcinoma.
Mitchell TJ; Rossi SH; Klatte T; Stewart GD
World J Urol; 2018 Dec; 36(12):1899-1911. PubMed ID: 30099580
[TBL] [Abstract][Full Text] [Related]
12. Clear cell renal cell carcinoma with wild-type von Hippel-Lindau gene: a non-existent or new tumour entity?
Batavia AA; Schraml P; Moch H
Histopathology; 2019 Jan; 74(1):60-67. PubMed ID: 30565303
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
14. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
Trotta AM; Santagata S; Zanotta S; D'Alterio C; Napolitano M; Rea G; Camerlingo R; Esposito F; Lamantia E; Anniciello A; Botti G; Longo N; Botti G; Pignata S; Perdonà S; Scala S
J Exp Clin Cancer Res; 2018 Dec; 37(1):297. PubMed ID: 30514329
[TBL] [Abstract][Full Text] [Related]
15. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
[TBL] [Abstract][Full Text] [Related]
16. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
[TBL] [Abstract][Full Text] [Related]
17. Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC.
Matsuda D; Khoo SK; Massie A; Iwamura M; Chen J; Petillo D; Wondergem B; Avallone M; Kloostra SJ; Tan MH; Koeman J; Zhang Z; Kahnoski RJ; ; Baba S; Teh BT
Cancer Lett; 2008 Dec; 272(2):260-7. PubMed ID: 18682315
[TBL] [Abstract][Full Text] [Related]
18. The expression pattern of Von Hippel-Lindau tumor suppressor protein, MET proto-oncogene, and TFE3 transcription factor oncoprotein in renal cell carcinoma in Upper Egypt.
Nagi FM; Omar AA; Mostafa MG; Mohammed EA; Abd-Elwahed Hussein MR
Ultrastruct Pathol; 2011 Apr; 35(2):79-86. PubMed ID: 21299348
[TBL] [Abstract][Full Text] [Related]
19. Requirement for the von Hippel-Lindau tumor suppressor gene for functional epidermal growth factor receptor blockade by monoclonal antibody C225 in renal cell carcinoma.
Perera AD; Kleymenova EV; Walker CL
Clin Cancer Res; 2000 Apr; 6(4):1518-23. PubMed ID: 10778984
[TBL] [Abstract][Full Text] [Related]
20. Clonal architectures predict clinical outcome in clear cell renal cell carcinoma.
Huang Y; Wang J; Jia P; Li X; Pei G; Wang C; Fang X; Zhao Z; Cai Z; Yi X; Wu S; Zhang B
Nat Commun; 2019 Mar; 10(1):1245. PubMed ID: 30886153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]